脓毒症诊断不确定性与抗生素时机:双轴决策模型观察性验证
该回顾性观察队列研究纳入2019年1月至2025年6月某大型城市安全网医疗系统成人急诊就诊199,062次,用随机森林模型估计持续抗生素治疗的感染概率P(treated infection),以3小时改良早期预警评分衡量生理严重度。结果显示抗生素时机随两轴联合升高呈连续梯度,交互项p=0.0013;在3小时后治疗的患者中,晚于双轴位置预期时机与3天ICU入住或住院死亡升高相关(p<0.001)。提示将双轴结构显式化有助于识别不必要实践变异。
要点
- 在199,062次成人急诊就诊中,P(treated infection)模型区分度良好(C-statistic 0.86),可用于量化疑似感染的感染概率。
- 抗生素时机随P(treated infection)与生理严重度(3小时MEWS)联合升高呈连续梯度,两轴及交互项均有显著贡献(交互p=0.0013)。
- 在3小时后接受抗生素治疗的患者中,晚于双轴位置预期时机与更高的3天ICU入住或住院死亡相关(校正后p<0.001)。
- 该研究为回顾性观察设计,仅显示关联而非因果,双轴模型需前瞻性验证后方可用于床旁决策支持。
适用人群与场景
- 2019年1月至2025年6月某大型城市安全网医疗系统成人急诊就诊患者,共199,062次急诊就诊。
- 模型开发集83,910次就诊,时间外推验证集115,152次急诊就诊。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:回顾性观察性队列研究,单中心(大型城市安全网医疗系统),使用结构化电子健康记录数据。
- 样本量:199,062次成人急诊就诊,其中83,910次用于模型开发,115,152次为时间外推验证集。
- 干预/暴露:以随机森林模型估计P(treated infection),以3小时改良早期预警评分衡量生理严重度。
- 主要终点:24小时内抗生素时机;抗生素时机随P(treated infection)与生理严重度联合升高呈连续梯度,限制性立方样条回归证实两轴及交互项显著(交互p=0.0013)。
- 关键次要终点:3小时后治疗患者中,晚于双轴位置预期时机与更高的3天ICU入住或住院死亡相关(校正P(treated infection)、生理严重度及交互后p<0.001)。
- 模型区分度:P(treated infection)模型C-statistic为0.86。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究。
- 局限:回顾性设计、单中心、观察性关联不能推断因果;双轴模型需前瞻性验证。
对床旁实践的改变
- 该研究提示临床医生在疑似脓毒症中可能同时整合感染概率与生理严重度来决定抗生素时机,偏离该双轴模式的延迟用药与不良结局相关。
- 双轴决策模型目前为观察性研究结论,尚不能作为床旁决策阈值或决策支持工具直接使用,需前瞻性验证。
- 原文未提及适用与不适用人群、纳入/排除标准及常见陷阱。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Sepsis treatment requires balancing the benefits of timely antibiotic administration against the risks of over-treatment under diagnostic uncertainty. Although treatment urgency likely reflects both the probability of infection and physiologic severity, this joint structure has not previously been quantified using real-world clinical data.
OBJECTIVES: To determine whether real-world antibiotic timing in the emergency department reflects a dual-axis pattern integrating probability of infection and physiologic severity.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective observational cohort study using structured electronic health record data from adult emergency department encounters at a large urban safety-net health system from January 2019 through June 2025. A random forest model estimated the probability of sustained antibiotic treatment, P(treated infection), for suspected infection from early demographic, physiologic, and laboratory data, and physiologic severity was measured using the Modified Early Warning Score at 3 hours.
MAIN OUTCOMES AND MEASURES: The primary outcome was time-to-antibiotics within 24 hours of presentation. The secondary outcome was a composite of ICU stay or in-hospital death among patients treated after 3 hours.
RESULTS: The study included 199,062 emergency department visits over 6.5 years. Of these, 83,910 visits were used for model development, and the remaining 115,152 emergency department encounters comprised a temporally held-out cohort used for model evaluation and downstream observational analyses. The P(treated infection) model demonstrated good discrimination (C-statistic, 0.86). Antibiotic timing followed a continuous gradient across jointly increasing P(treated infection) and physiologic severity, and restricted cubic spline regression confirmed significant contributions from both axes and their interaction (interaction, p = 0.0013). Among patients treated after 3 hours, antibiotic timing later-than-expected based on a patient's dual-axis position was associated with a higher rate of 3-day ICU stay or in-hospital death after adjustment for P(treated infection), physiologic severity, and their interaction (p < 0.001).
CONCLUSIONS: Real-world antibiotic timing in suspected sepsis appears to reflect a dual-axis pattern consistent with clinicians integrating P(treated infection) and physiologic severity. Making this structure explicit may help identify unwarranted practice variation and inform future decision support strategies for timely treatment.
参考来源
- Currey D, Siff J, Sahoo S, et al. Diagnostic Uncertainty and Antibiotic Timing in Sepsis: Observational Validation of a Dual-Axis Decision Model. Crit Care Explor. 2026. PMID: 42720074. doi:10.1097/CCE.0000000000001472
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。